Author

G. Kristiansen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

A. Bicker· 1 shared A. Buchner· 1 shared A. Marchetto· 1 shared C. Stief· 1 shared D. Nettersheim· 1 shared F. Cidre-Aranaz· 1 shared F. Guscetti· 1 shared F. S. Wehweck· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bicker

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyInternational Journal of Molecular SciencesPeer-reviewedSep 29, 2022

Pro-apoptotic and anti-invasive properties underscore the tumor suppressing impact of myoglobin on subset of human breast cancer cells

M. A. Aboouf, J. Armbruster, M. Thiersch…·T. A. Gorr

This study shows that myoglobin suppresses tumor growth in breast cancer cells by promoting apoptosis and reducing invasiveness.

DOI 10.3390/ijms231911483

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyInternational Journal of CancerPeer-reviewedNov 1, 2019

Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumour fate

S. Jostes, M. Fellermeyer, G. Merges…·H. Schorle

This study compares SOX17 and SOX2 binding patterns in germ cell tumors and somatic cells, showing SOX17 maintains pluripotency in seminomas while SOX2 does so in embryonal carcinomas.

DOI 10.1002/ijc.32714

𝕏 PostBluesky

Cancer BiologybioRxivFeb 10, 2019

Biomarker-based outcome prediction in prostate adenocarcinoma depends on the TMPRSS2-ERG status

J. S. Gerke, M. F. Orth, Y. Tolkach…·T. G. P. Grunewald

This study identifies subtype-specific prognostic biomarkers in prostate adenocarcinoma, showing that their prognostic value depends on TMPRSS2-ERG fusion status.

DOI 10.1002/ijc.32792

humanbulk RNA-seq

𝕏 PostBluesky